Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Goodwill & Intangibles (2017 - 2025)

Historic Goodwill & Intangibles for Adma Biologics (ADMA) over the last 9 years, with Q3 2025 value amounting to $4.0 million.

  • Adma Biologics' Goodwill & Intangibles fell 5579.38% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 5579.38%. This contributed to the annual value of $4.0 million for FY2024, which is 5438.44% down from last year.
  • Per Adma Biologics' latest filing, its Goodwill & Intangibles stood at $4.0 million for Q3 2025, which was down 5579.38% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Goodwill & Intangibles registered a high of $9.6 million during Q1 2021, and its lowest value of $4.0 million during Q1 2025.
  • Over the past 5 years, Adma Biologics' median Goodwill & Intangibles value was $8.5 million (recorded in 2021), while the average stood at $7.8 million.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first skyrocketed by 654.83% in 2024, then plummeted by 5579.38% in 2025.
  • Adma Biologics' Goodwill & Intangibles (Quarter) stood at $8.5 million in 2021, then grew by 0.0% to $8.5 million in 2022, then grew by 2.46% to $8.7 million in 2023, then tumbled by 54.38% to $4.0 million in 2024, then increased by 0.78% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $4.1 million for Q2 2025, and $4.0 million during Q1 2025.